Oral administration of recombinant cholera toxin subunit B inhibits IL-12 mediated murine experimental colitis.

被引：0
|
作者：
Boirivant, M
Fuss, IJ
Ferroni, L
De Pascale, M
Strober, W
机构：
[1] Inst Super Sanita, Rome, Italy
[2] NIH, Lci, Mis, Bethesda, MD 20892 USA
[3] ISS, Immunol Lab, Rome, Italy
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)84420-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2982
引用
收藏
页码：A571 / A571
页数：1
相关论文
共 50 条
  • [21] Cholera toxin inhibits IL-12 production and CD8α+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function
    la Sala, Andrea
    He, Jianping
    Laricchia-Robbio, Leopoldo
    Gorini, Stefania
    Iwasaki, Akiko
    Braun, Michael
    Yap, George S.
    Sher, Alan
    Ozato, Keiko
    Kelsall, Brian
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (06): : 1227 - 1235
  • [22] DELIVERY OF THE CHOLERA TOXIN-B SUBUNIT BY USING A RECOMBINANT YERSINIA-ENTEROCOLITICA STRAIN AS A LIVE ORAL CARRIER
    SORY, MP
    CORNELIS, GR
    [J]. RESEARCH IN MICROBIOLOGY, 1990, 141 (7-8) : 921 - 929
  • [23] Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system
    Harokopakis, E
    Hajishengallis, G
    Michalek, SM
    [J]. INFECTION AND IMMUNITY, 1998, 66 (09) : 4299 - 4304
  • [24] Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant
    Isaka, M
    Yasuda, Y
    Mizokami, M
    Kozuka, S
    Taniguchi, T
    Matano, K
    Maeyama, J
    Mizuno, K
    Morokuma, K
    Ohkuma, K
    Goto, N
    Tochikubo, K
    [J]. VACCINE, 2001, 19 (11-12) : 1460 - 1466
  • [25] Immune responses to the oral administration of recombinant Bacillus subtilis expressing multi-epitopes of foot-and-mouth disease virus and a cholera toxin B subunit
    Hu, Bo
    Li, Chang
    Lu, Huijun
    Zhu, Zhanbo
    Du, Shouwen
    Ye, Ming
    Tan, Lei
    Ren, Dayong
    Han, Jiali
    Kan, Shifu
    Wang, Jing
    Jin, Ningyi
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2011, 171 (01) : 272 - 279
  • [26] Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit
    Sun, JB
    Li, BL
    Czerkinsky, C
    Holmgren, J
    [J]. CLINICAL IMMUNOLOGY, 2000, 97 (02) : 130 - 139
  • [27] Prevention of alveolar bone resorption by intranasal administration of Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit in mice.
    Takahashi, Y.
    Kumada, H.
    Hamada, N.
    Ozono, S.
    Haishima, Y.
    Isaka, M.
    Yasuda, Y.
    Tochikubo, K.
    Umemoto, T.
    [J]. JOURNAL OF DENTAL RESEARCH, 2003, 82 : B281 - B281
  • [28] Induction and distribution of intestinal immune responses after administration of recombinant cholera toxin B subunit in the ileal pouches of colectomized patients
    Kilhamn, J
    Brevinge, H
    Quiding-Järbrink, M
    Svennerholm, AM
    Jertborn, M
    [J]. INFECTION AND IMMUNITY, 2001, 69 (05) : 3466 - 3471
  • [29] THERMAL-STABILITY OF AN ORAL KILLED-CHOLERA WHOLE-CELL VACCINE CONTAINING RECOMBINANT B-SUBUNIT OF CHOLERA-TOXIN
    AHMED, ZU
    HOQUE, MM
    RAHMAN, ASMH
    SACK, RB
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 1994, 38 (11) : 837 - 842
  • [30] Tangeretin Inhibits IL-12 Expression and NF-κB Activation in Dendritic Cells and Attenuates Colitis in Mice
    Eun, Su-Hyeon
    Woo, Je-Te
    Kim, Dong-Hyun
    [J]. PLANTA MEDICA, 2017, 83 (06) : 527 - 533
12345